Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

Codirap

Diseases
Sclerotinia, Phomosis, Cylindrosporiosis
Country
France
Registration Year
2011
Manufacturer
Caussade Semences S.A.
Offers: 1
Where to buy
Price range
827.99 - 827.99 UAH
Views
10
Reviews
0
Producer
Caussade Semences S.A.
Description Codirap
Codirap — this is a medium-early maturing winter rapeseed hybrid, distinguished by high productivity and adaptability to various soil-climatic conditions in Ukraine. The potential yield of this variety reaches 55 c/ha. Rapeseed exhibits rapid early growth after sowing and in early spring, promoting abundant branching and formation of a large number of pods. It is adaptable to various soil types and cultivation technologies, making it suitable for diverse agronomic conditions. Codirap shows high resistance to major stem and pod diseases such as phomopsis, sclerotinia, stem canker, and cylindrosporiosis, as well as to certain pests. This variety tolerates temperature fluctuations well, is frost-resistant, and drought-tolerant. Low levels of glucosinolates and erucic acid ensure high oil quality and product safety. Codirap seeds are produced by the French company Caussade Semences and are non-GMO. Rapeseed is characterized by high germination energy and good branching capacity, ensuring optimal seeding density of 30–35 plants per square meter during spring vegetation renewal. Packaging is available in bags containing approximately 15 million seeds, which is convenient for agronomic use and large-scale cultivation.
Specifications Codirap
Diseases
Sclerotinia
Sclerotiniosis
Phomosis
Phomosis
Cylindrosporiosis
Cylindrosporiosis
Type of Rape
Winter rape
Hybrid Type
Population (Variety)
Yield Potential
50-60 cu/ha
Glucosinolate Content, mmol
9-10
Erucic Acid Content
Low
Plant: Branching
High
Country
France
Registration Year
2011
Catalog
Varieties
Technical Crops
Manufacturer
Caussade Semences S.A.
Where to buy Codirap
Loading...
Reviews Codirap
0comments
Sort by:Popular first
No comments yet.